Whole-Body [ 18 F ]-FDG-PET / MRI for Oncology : A Consensus Recommendation * Konsensempfehlungen zur Anwendung der Ganzkörper [ 18 F ]-FDG-PET / MRT in der onkologischen Bildgebung

Combined PET/MR imaging (PET/MRI) was proposed for patient management in 2006 with first commercial versions of integrated whole-body systems becoming available as of 2010. PET/MRI followed the prior evolution of hybrid imaging as attested by the successful adoption of combined PET/CT and SPECT/CT since the early 2000 s. Today, around 150 whole-body PET/MRI systems have become operational worldwide. One of the main application fields of PET/MRI is oncologic imaging. Despite the increasing use of PET/MRI, little governance regarding standardized PET/MRI protocols has been provided to date. Standardization and harmonization of imaging protocols is, however, mandatory for efficient on-site patient management and multi-center studies. This document summarizes consensus recommendations on key aspects of patient referral and preparation, PET/MRI workflow and imaging protocols, as well as reporting strategies for whole-body [18F]-FDG-PET/MRI. These recommendations were created by early adopters and key experts in the field of PET, MRI and PET/MRI. This document is intended to provide guidance for the harmonization and standardization of PET/MRI today and to support wider clinical adoption of this imaging modality for the benefit of patients. CITATION FORMAT: · Umutlu L, Beyer T, Grueneisen JS et al. Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation. Fortschr Röntgenstr 2019; 191: 289 - 297.

[1]  D. Vigneron,et al.  Quantitative Evaluation of Atlas-based Attenuation Correction for Brain PET in an Integrated Time-of-Flight PET/MR Imaging System. , 2017, Radiology.

[2]  Eric J. W. Visser,et al.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  V. Kapoor,et al.  An introduction to PET-CT imaging. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[4]  Magdalena Rafecas,et al.  A prototype high-resolution animal positron tomograph with avalanche photodiode arrays and LSO crystals , 2001, European Journal of Nuclear Medicine.

[5]  P. Veit-Haibach,et al.  PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison , 2015, European Radiology.

[6]  T. Beyer,et al.  The future of hybrid imaging—part 3: PET/MR, small-animal imaging and beyond , 2011, Insights into imaging.

[7]  T. Beyer,et al.  Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites , 2016, The Journal of Nuclear Medicine.

[8]  Johan Nuyts,et al.  Completion of a truncated attenuation image from the attenuated PET emission data , 2013, IEEE Nuclear Science Symposuim & Medical Imaging Conference.

[9]  R. Günther,et al.  Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  Felix Nensa,et al.  Clinical applications of PET/MRI: current status and future perspectives. , 2014, Diagnostic and interventional radiology.

[11]  Patrick Veit-Haibach,et al.  Workflow Considerations in PET/MR Imaging , 2014, The Journal of Nuclear Medicine.

[12]  G. Hermosillo,et al.  Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone , 2015, The Journal of Nuclear Medicine.

[13]  G. Antoch,et al.  Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer. , 2016, European journal of radiology.

[14]  G. Antoch,et al.  Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT? , 2015, Nuclear medicine communications.

[15]  J. Czernin,et al.  18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients , 2016, The Journal of Nuclear Medicine.

[16]  Marc Kachelriess,et al.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  M. Spieth,et al.  A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  Markus Schwaiger,et al.  Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology , 2012, The Journal of Nuclear Medicine.

[19]  A. Drzezga,et al.  First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses , 2012, The Journal of Nuclear Medicine.

[20]  Sune H. Keller,et al.  Image artifacts from MR-based attenuation correction in clinical, whole-body PET/MRI , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[21]  Alan Britten,et al.  Routine quality control recommendations for nuclear medicine instrumentation , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  Thomas L. Morgan,et al.  Quality Assurance for PET and PET/CT Systems , 2012 .

[23]  K. Scheffler,et al.  MR‐based field‐of‐view extension in MR/PET: B0 homogenization using gradient enhancement (HUGE) , 2013, Magnetic resonance in medicine.

[24]  N. Willich,et al.  FDG-PET/CT in oncology , 2007, Nuklearmedizin.

[25]  M. Hood.  Reference Manual for Magnetic Resonance Safety, Implants, and Devices , 2016 .

[26]  Patrick Dupont,et al.  Simultaneous maximum a posteriori reconstruction of attenuation and activity distributions from emission sinograms , 1999, IEEE Transactions on Medical Imaging.

[27]  J. Czernin,et al.  Does PET/MR Imaging Improve Cancer Assessments? Literature Evidence from More Than 900 Patients , 2014, The Journal of Nuclear Medicine.

[28]  G. Hermosillo,et al.  Dixon Sequence with Superimposed Model-Based Bone Compartment Provides Highly Accurate PET/MR Attenuation Correction of the Brain , 2016, The Journal of Nuclear Medicine.

[29]  H. Quick,et al.  Field of view extension and truncation correction for MR-based human attenuation correction in simultaneous MR/PET imaging. , 2014, Medical physics.

[30]  R. Boellaard,et al.  Investigating the state-of-the-art in whole-body MR-based attenuation correction: an intra-individual, inter-system, inventory study on three clinical PET/MR systems , 2016, Magnetic Resonance Materials in Physics, Biology and Medicine.

[31]  F. Wiesinger,et al.  Evaluation of Sinus/Edge-Corrected Zero-Echo-Time–Based Attenuation Correction in Brain PET/MRI , 2017, The Journal of Nuclear Medicine.

[32]  Nassir Navab,et al.  Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data , 2009, Journal of Nuclear Medicine.

[33]  B. Rosen,et al.  Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo) , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  T. Bathen,et al.  The Effect of Including Bone in Dixon-Based Attenuation Correction for 18F-Fluciclovine PET/MRI of Prostate Cancer , 2018, The Journal of Nuclear Medicine.

[35]  N. Schwenzer,et al.  Segmentation-Based Attenuation Correction in Positron Emission Tomography/Magnetic Resonance: Erroneous Tissue Identification and Its Impact on Positron Emission Tomography Interpretation , 2015, Investigative radiology.

[36]  Harald H Quick,et al.  Hybrid Positron Emission Tomography/Magnetic Resonance Imaging: Challenges, Methods, and State of the Art of Hardware Component Attenuation Correction , 2016, Investigative radiology.

[37]  Steffen Sammet,et al.  Magnetic resonance safety , 2016, Abdominal Radiology.

[38]  Gudrun Wagenknecht,et al.  MRI for attenuation correction in PET: methods and challenges , 2012, Magnetic Resonance Materials in Physics, Biology and Medicine.

[39]  Heinz-Peter Schlemmer,et al.  PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications , 2010, Journal of Nuclear Medicine.

[40]  Harald H Quick,et al.  Current image acquisition options in PET/MR. , 2015, Seminars in nuclear medicine.

[41]  P. Høilund-Carlsen,et al.  FDG PET/CT in cancer: comparison of actual use with literature-based recommendations , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[42]  Ciprian Catana,et al.  PET/MRI in the Presence of Metal Implants: Completion of the Attenuation Map from PET Emission Data , 2017, The Journal of Nuclear Medicine.

[43]  T. A. Smith,et al.  FDG uptake, tumour characteristics and response to therapy: A review , 1998, Nuclear medicine communications.

[44]  Paul Kinahan,et al.  Attenuation correction for a combined 3D PET/CT scanner. , 1998, Medical physics.

[45]  R. Pooley.  AAPM/RSNA physics tutorial for residents: fundamental physics of MR imaging. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[46]  I. Carrió.  EANM-ESR white paper on multimodality imaging , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[47]  Michael Forsting,et al.  Implementation of FAST-PET/MRI for whole-body staging of female patients with recurrent pelvic malignancies: A comparison to PET/CT. , 2015, European journal of radiology.

[48]  H. Quick.  Integrated PET/MR , 2014, Journal of magnetic resonance imaging : JMRI.

[49]  Harald H Quick,et al.  MR‐based truncation and attenuation correction in integrated PET/MR hybrid imaging using HUGE with continuous table motion , 2017, Medical physics.

[50]  C. Kuhl,et al.  Sensitivity encoding for diffusion-weighted MR imaging at 3.0 T: intraindividual comparative study. , 2005, Radiology.

[51]  R. Boellaard,et al.  Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany , 2017, Molecular Imaging and Biology.

[52]  C Marini,et al.  Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[53]  Frank G. Shellock,et al.  Reference Manual for Magnetic Resonance Safety, Implants, and Devices , 2009 .

[54]  Bernd J Pichler,et al.  Combined PET/MR: A Technology Becomes Mature , 2015, The Journal of Nuclear Medicine.

[55]  A. Wetter,et al.  Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI , 2016, PloS one.

[56]  Mathew R Divine,et al.  Preclinical and Translational PET/MR Imaging , 2014, The Journal of Nuclear Medicine.

[57]  Lino Morris Sawicki,et al.  Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT , 2017, PloS one.

[58]  I. Burger,et al.  PET/MR imaging of bone lesions – implications for PET quantification from imperfect attenuation correction , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[59]  C. Claussen,et al.  Simultaneous Mr/pet Imaging of the Human Brain: Feasibility Study 1 , 2022 .

[60]  F. Landoni,et al.  Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[61]  N. Willich,et al.  [FDG-PET/CT in oncology. German Guideline]. , 2007, Nuklearmedizin. Nuclear medicine.

[62]  Ciprian Catana,et al.  Motion correction options in PET/MRI. , 2015, Seminars in nuclear medicine.

[63]  Maike E Lindemann,et al.  Impact of improved attenuation correction featuring a bone atlas and truncation correction on PET quantification in whole-body PET/MR , 2018, European Journal of Nuclear Medicine and Molecular Imaging.